Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature Medicine 9, 1287 - 1292 (2003)
Published online: 21 September 2003 | doi:10.1038/nm933
Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses
Simona Stäger1, James Alexander2, Alun C Kirby1, Marina Botto3, Nico Van Rooijen4, Deborah F Smith5, Frank Brombacher6 & Paul M Kaye1
Abstract
CD8+ T cells are essential for long-term, vaccine-induced resistance against intracellular pathogens. Here we show that natural antibodies, acting in concert with complement, are endogenous adjuvants for the generation of protective CD8+ T cells after vaccination against visceral leishmaniasis. IL-4 was crucial for the priming of vaccine-specific CD8+ T cells, and we defined the primary source of IL-4 as a CD11b+CD11clo phagocyte. IL-4 secretion was not observed in antibody-deficient mice and could be reconstituted with serum from normal, but not Btk immune-deficient, mice. Similarly, no IL-4 response or CD8+ T-cell priming was seen in C1qa-/- mice. These results identify a new pathway by which immune complex–mediated complement activation can regulate T-cell-mediated immunity. We propose that this function of natural antibodies could be exploited when developing new vaccines for infectious diseases.
To read this story in full you will need to login or make a payment (see right).
